Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Embella deoxycholic acid injection for flank fat reduction
IRCT20240416061507N1Phase 4Completed
- Sponsor
- Espad Pharmed
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sodium deoxycholate, sponsored by Espad Pharmed. Primary endpoints: Adverse events, Seriousness of adverse events and 4 more. Started Aug 2024; status: completed.
02
Drugs
sodium deoxycholate
Beyond the preview
Go deeper on IRCT20240416061507N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240416061507N1.